Cohance Lifesciences Limited
COHANCE
Rankning i aktier
#6383
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktiekurs
$5.05
Senast synkroniserad: 2026-10-19
Marknadsvärde
$1.93B
Förändring (1 dag)
-1.44%
Förändring (1 år)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
EPS för Cohance Lifesciences Limited (COHANCE)
EPS per June 2025 TTM: $0.11
Enligt Cohance Lifesciences Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $0.11. Vid slutet av 2024 hade bolaget ett EPS på $0.14, en minskning jämfört med EPS från 2023 som var $0.20.
EPS-historik för Cohance Lifesciences Limited från 2019 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
